Post your job infront of 100,000+ qualified LP's and GP's.
Recently Filled Jobs
Firms you might be interested in
Tessera Therapeutics Attracts Over $230M In Series B Financing To Advance ‘gene Writing’ – A New Category In Genetic Medicine
Posted on: Jan. 12, 2021, 10:11 p.m.
Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance ‘Gene Writing’ – A New Category in Genetic Medicine SoftBank Vision Fund 2, Alaska Permanent Fund Corporation, Altitude Life Science Ventures, Qatar Investment Authority, and Other New Investors Provide Growth Capital to Fuel Pioneering Platform from Flagship Labs CAMBRIDGE, Mass., January 12, 2021-- Tessera Therapeutics, an early-stage life sciences company founded by Flagship Pioneering, announced today that it has raised over $230M in Series B financing. Full investment news articleRelevent to this post: QIA Louisiana Economic Development,